147 related articles for article (PubMed ID: 32578373)
1. Prognostic value of expanded liver transplantation criteria-the 5-5-500 rule-in patients with hepatic resection for intermediate-stage hepatocellular carcinoma.
Shinkawa H; Tanaka S; Takemura S; Amano R; Kimura K; Kinoshita M; Miyazaki T; Kubo S
J Hepatobiliary Pancreat Sci; 2020 Oct; 27(10):682-689. PubMed ID: 32578373
[TBL] [Abstract][Full Text] [Related]
2. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
[TBL] [Abstract][Full Text] [Related]
3. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.
Furukawa K; Shiba H; Horiuchi T; Shirai Y; Haruki K; Fujiwara Y; Sakamoto T; Gocho T; Yanaga K
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):199-205. PubMed ID: 28160422
[TBL] [Abstract][Full Text] [Related]
6. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
[TBL] [Abstract][Full Text] [Related]
7. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
8. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Wang X; Wang Z; Wu L
BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
10. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
12. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
[TBL] [Abstract][Full Text] [Related]
13. Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
Santambrogio R; Opocher E; Costa M; Barabino M; Zuin M; Bertolini E; De Filippi F; Bruno S
Ann Surg Oncol; 2012 Feb; 19(2):426-34. PubMed ID: 21732145
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center.
Garancini M; Nespoli S; Romano F; Uggeri F; Degrate L; Okolicsanyi S; Gianotti L
J Visc Surg; 2018 Sep; 155(4):275-282. PubMed ID: 29606603
[TBL] [Abstract][Full Text] [Related]
15. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
16. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
[TBL] [Abstract][Full Text] [Related]
17. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U;
Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y
Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546
[TBL] [Abstract][Full Text] [Related]
19. Liver resection for HCC outside the BCLC criteria.
Bhandare MS; Patkar S; Shetty N; Polnaya A; Kulkarni S; Dusane RR; Shrikhande SV; Goel M
Langenbecks Arch Surg; 2018 Feb; 403(1):37-44. PubMed ID: 29199380
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]